^
BIOMARKER:

ALK negative

i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Entrez ID:
ALK negative
NSCLC
pembrolizumab
Sensitive: A2 - Guideline
ALK negative
Mantle Cell Lymphoma
brentuximab vedotin
Sensitive: A2 - Guideline
ALK negative
T Cell Non-Hodgkin Lymphoma
brentuximab vedotin
Sensitive: B - Late Trials
ALK negative
NHL
brentuximab vedotin
Sensitive: B - Late Trials
ALK negative
NSCLC
pembrolizumab + atezolizumab
Sensitive: B - Late Trials
ALK negative
NHL
etoposide IV
Sensitive: C3 – Early Trials
ALK negative
NSCLC
sintilimab
Sensitive: C3 – Early Trials